EUVIMEDEUVIMED entdecken
Open Access

Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/ DICER1 Registry

Kelly N Hagedorn iD, Alexander T Nelson iD, Alexander J Towbin iD, Nicole Frederickson, Paige Mallinger, John T Lucas iD, Louis P Dehner, Yoav H Messinger iD, Barry L Shulkin iD, William A Mize, Kris Ann P Schultz iD

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Kelly N Hagedorn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Children's Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Bone Neoplasms, Fluorodeoxyglucose F18. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pleuropulmonary blastoma (PPB) is the most common primary lung neoplasm of infancy and early childhood. Given the rarity of PPB, the role of positron emission tomography (PET) and bone scintigraphy (bone scans) in diagnostic evaluation and surveillance has not been documented to date. Available PET and bone scan data are presented in this study. Procedures Patients with PPB enrolled in the International PPB/ DICER1 Registry and available PET imaging and/or bone scan reports were retrospectively abstracted.

Results

On retrospective analysis, 133 patients with type II and III (advanced) PPB were identified with available report(s) (PET scan only = 34, bone scan only = 83, and both bone scan and PET = 16). All advanced primary PPB ( n = 11) and recurrent ( n = 8) tumors prior to treatment presented with 18 F‐fluorodeoxyglucose (FDG)‐avid lesions, with median maximum standardized uptake values of 7.4 and 6.7, respectively. False positive FDG uptake in the thorax was noted during surveillance (specificity: 59%). Bone metastases were FDG‐avid prior to treatment. Central nervous system metastases were not discernable on PET imaging. Sensitivity and specificity of bone scans for metastatic bone disease were 89% and 92%, respectively. Bone scans had a negative predictive value of 99%, although positive predictive value was 53%. Four patients with distant bone metastases had concordant true positive bone scan and PET.

Conclusion

Primary, recurrent, and/or extracranial metastatic PPB presents with an FDG‐avid lesion on PET imaging. Additional prospective studies are needed to fully assess the utility of nuclear medicine imaging in surveillance for patients with advanced PPB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsFluorodeoxyglucose F18Sensitivity and SpecificityRetrospective StudiesPositron-Emission TomographyRadionuclide ImagingChild, PreschoolRadiopharmaceuticalsPulmonary BlastomaDEAD-box RNA HelicasesRegistriesHumansRibonuclease III

Stichwörter der Autor:innen

DICER1DICER1-related tumor predispositionPETbone scanpleuropulmonary blastomatype II PPBtype III PPB

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsDICER1 protein, humanRibonuclease IIIDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Department of Radiology, Children's Minnesota, Minneapolis, Minnesota, USA.
  • International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, Minnesota, USA.
  • International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, Minnesota, USA.
  • Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota, USA.
  • University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

ORCID-Profile: Kelly N Hagedorn, Alexander T Nelson, Alexander J Towbin, John T Lucas, Yoav H Messinger, Barry L Shulkin, Kris Ann P Schultz

Förderung

  • NCI NIH HHS

Zitieren

APA

Hagedorn, K. N., Nelson, A. T., Towbin, A. J., Frederickson, N., Mallinger, P., Lucas, J. T., Dehner, L. P., Messinger, Y. H., Shulkin, B. L., Mize, W. A., & Schultz, K. A. P. (2023). Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/ DICER1 Registry. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30628

Vancouver

Hagedorn KN, Nelson AT, Towbin AJ, Frederickson N, Mallinger P, Lucas JT, et al. Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/ DICER1 Registry. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30628

BibTeX
@article{Hagedorn2023,
  author = {Hagedorn, Kelly N and Nelson, Alexander T and Towbin, Alexander J and Frederickson, Nicole and Mallinger, Paige and Lucas, John T and Dehner, Louis P and Messinger, Yoav H and Shulkin, Barry L and Mize, William A and Schultz, Kris Ann P},
  title = {Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/ DICER1 Registry},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30628}
}
Kostenlos starten →